Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Morgan Stanley to Evaluate Buyout Offer for Tongjitang

publication date: Mar 26, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

The offer to take Tongjitang Chinese Medicines (NYSE: TCM) private will be put in the lap of Morgan Stanley to determine whether the offer represents a fair price for the company. A special committee of the Board of Directors, composed of TCM’s two independent directors, appointed Morgan Stanley Asia Limited to be their financial advisor for the transaction. More details...

Stock Symbol: (NYSE: TCM)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners